4//SEC Filing
Walter Matthew R. 4
Accession 0001613103-25-000134
CIK 0001613103other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:21 PM ET
Size
15.4 KB
Accession
0001613103-25-000134
Insider Transaction Report
Form 4
Walter Matthew R.
SVP, Chief HR Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-08-01+2,179→ 32,804 total - Exercise/Conversion
Ordinary Shares
2025-08-01$78.00/sh+963$75,114→ 32,736 total - Exercise/Conversion
Performance Share Unit
2025-08-01−2,179→ 0 total→ Ordinary Shares (2,179 underlying) - Tax Payment
Ordinary Shares
2025-08-01$89.34/sh−879$78,530→ 31,857 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-01−963→ 0 totalExercise: $78.00Exp: 2025-08-03→ Ordinary Shares (963 underlying) - Tax Payment
Ordinary Shares
2025-08-01$89.34/sh−667$59,590→ 32,137 total - Tax Payment
Ordinary Shares
2025-08-01$89.34/sh−364$32,520→ 31,773 total
Footnotes (6)
- [F1]Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
- [F2]Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
- [F3]Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
- [F4]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- [F5]The performance share units vested on August 1, 2025.
- [F6]These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Documents
Issuer
Medtronic plc
CIK 0001613103
Entity typeother
Related Parties
1- filerCIK 0002028475
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:21 PM ET
- Size
- 15.4 KB